Qlucore
Private Company
Total funding raised: $800K
Overview
Qlucore is a private, revenue-generating diagnostics and software company based in Lund, Sweden, specializing in AI/machine learning-powered bioinformatics tools. The company's primary offerings include Qlucore Omics Explorer for research, Qlucore Insights for disease subtyping, and the IVDR-certified Qlucore Diagnostics for pediatric leukemia. By focusing on intuitive, visualization-driven analysis, Qlucore aims to bridge the gap between complex genomic data and practical application in both research and clinical settings, with a particular emphasis on advancing precision medicine and cancer diagnostics.
Technology Platform
Proprietary visualization-based software engine for interactive statistical analysis and exploration of multi-omics data (e.g., RNA-seq, proteomics, qPCR). Features dynamic visualization, real-time filtering, and supports custom R scripting. Platform underpins both research (RUO) and IVDR-certified clinical diagnostic tools.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Qlucore competes in the bioinformatics software market against large commercial suites (e.g., Qiagen CLC, Partek Flow, Thermo Fisher), open-source platforms (R/Bioconductor), and other visualization-focused startups. In clinical diagnostics, it competes with established diagnostic companies and laboratory-developed test (LDT) workflows. Its key differentiation is its emphasis on intuitive, interactive visualization for non-bioinformaticians.